1	Clinical	Clinical	B-NP	JJ	B-protein	2	NMOD
2	factors	factor	I-NP	NNS	I-protein	0	ROOT
3	associated	associate	B-VP	VBN	O	2	NMOD
4	with	with	B-PP	IN	O	3	VMOD
5	development	development	B-NP	NN	O	4	PMOD
6	of	of	B-PP	IN	O	5	NMOD
7	severe-complicated	severe-complicated	B-NP	JJ	O	10	NMOD
8	Clostridium	Clostridium	I-NP	NN	O	10	NMOD
9	difficile	difficile	I-NP	NN	O	10	NMOD
10	infection	infection	I-NP	NN	O	6	PMOD
11	.	.	O	.	O	2	P

1	Clostridium	Clostridium	B-NP	NN	O	3	NMOD
2	difficile	difficile	I-NP	JJ	O	3	NMOD
3	infection	infection	I-NP	NN	O	7	SUB
4	(	(	O	(	O	6	DEP
5	CDI	CDI	B-NP	NN	B-protein	6	DEP
6	)	)	O	)	O	3	NMOD
7	can	can	B-VP	MD	O	0	ROOT
8	cause	cause	I-VP	VB	O	7	VC
9	life-threatening	life-threatening	B-NP	JJ	O	10	NMOD
10	complications	complication	I-NP	NNS	O	8	OBJ
11	.	.	O	.	O	7	P

1	Severe-complicated	Severe-complicated	B-NP	JJ	O	2	NMOD
2	CDI	CDI	I-NP	NN	O	3	SUB
3	is	be	B-VP	VBZ	O	0	ROOT
4	characterized	characterize	I-VP	VBN	O	3	VC
5	by	by	B-PP	IN	O	4	VMOD
6	hypotension	hypotension	B-NP	NN	O	18	NMOD
7	,	,	O	,	O	18	P
8	shock	shock	B-NP	NN	O	18	NMOD
9	,	,	O	,	O	18	P
10	sepsis	sepsis	B-NP	NN	O	18	NMOD
11	,	,	O	,	O	18	P
12	ileus	ileus	B-NP	NN	O	18	NMOD
13	,	,	O	,	O	18	P
14	megacolon	megacolon	B-NP	NN	O	18	NMOD
15	,	,	O	,	O	18	P
16	and	and	O	CC	O	18	NMOD
17	colon	colon	B-NP	NN	O	18	NMOD
18	perforation	perforation	I-NP	NN	O	5	PMOD
19	.	.	O	.	O	3	P

1	We	We	B-NP	PRP	O	2	SUB
2	created	create	B-VP	VBD	O	0	ROOT
3	a	a	B-NP	DT	O	4	NMOD
4	model	model	I-NP	NN	O	2	OBJ
5	to	to	B-VP	TO	O	6	VMOD
6	identify	identify	I-VP	VB	O	4	NMOD
7	clinical	clinical	B-NP	JJ	O	8	NMOD
8	factors	factor	I-NP	NNS	O	6	OBJ
9	associated	associate	B-VP	VBN	O	8	NMOD
10	with	with	B-PP	IN	O	9	VMOD
11	severe-complicated	severe-complicated	B-NP	JJ	O	12	NMOD
12	CDI	CDI	I-NP	NNP	O	10	PMOD
13	.	.	O	.	O	2	P

1	We	We	B-NP	PRP	O	2	SUB
2	analyzed	analyze	B-VP	VBD	O	0	ROOT
3	data	datum	B-NP	NNS	O	2	OBJ
4	from	from	B-PP	IN	O	3	NMOD
5	1446	1446	B-NP	CD	O	7	NMOD
6	inpatient	inpatient	I-NP	NN	O	7	NMOD
7	cases	case	I-NP	NNS	O	4	PMOD
8	of	of	B-PP	IN	O	7	NMOD
9	CDI	CDI	B-NP	NN	O	8	PMOD
10	(	(	O	(	O	25	DEP
11	48.6	48.6	B-NP	CD	O	13	NMOD
12	%	%	I-NP	NN	O	13	NMOD
13	female	female	I-NP	NN	O	24	NMOD
14	;	;	O	:	O	24	P
15	median	median	B-NP	JJ	O	16	NMOD
16	age	age	I-NP	NN	O	19	NMOD
17	,	,	O	,	O	19	P
18	62.5	62.5	B-NP	CD	O	19	NMOD
19	years	year	I-NP	NNS	O	24	NMOD
20	;	;	O	:	O	24	P
21	range	range	B-NP	NN	O	24	NMOD
22	,	,	O	,	O	24	P
23	0.1-103.7	0.1-103.7	B-NP	CD	O	24	NMOD
24	years	year	I-NP	NNS	O	25	DEP
25	)	)	O	)	O	9	NMOD
26	at	at	B-PP	IN	O	3	NMOD
27	the	the	B-NP	DT	O	29	NMOD
28	Mayo	Mayo	I-NP	NNP	O	29	NMOD
29	Clinic	Clinic	I-NP	NNP	O	26	PMOD
30	from	from	B-PP	IN	O	29	NMOD
31	June	June	B-NP	NNP	O	30	PMOD
32	28	28	I-NP	CD	O	31	NMOD
33	,	,	I-NP	,	O	31	P
34	2007	2007	I-NP	CD	O	31	NMOD
35	,	,	O	,	O	31	P
36	to	to	B-PP	TO	O	30	PMOD
37	June	June	B-NP	NNP	O	36	PMOD
38	25	25	I-NP	CD	O	37	NMOD
39	,	,	I-NP	,	O	37	P
40	2010	2010	I-NP	CD	O	37	NMOD
41	.	.	O	.	O	2	P

1	Patients	Patient	B-NP	NNS	O	9	SUB
2	with	with	B-PP	IN	O	1	NMOD
3	severe-complicated	severe-complicated	B-NP	JJ	O	4	NMOD
4	CDI	CDI	I-NP	NN	O	2	PMOD
5	(	(	O	(	O	8	DEP
6	n =	n =	B-NP	NN	B-protein	8	DEP
7	487	487	I-NP	CD	I-protein	6	NMOD
8	)	)	O	)	O	4	NMOD
9	were	be	B-VP	VBD	O	0	ROOT
10	identified	identify	I-VP	VBN	O	9	VC
11	as	as	B-PP	IN	O	10	VMOD
12	those	those	B-NP	DT	O	11	PMOD
13	who	who	B-NP	WP	O	12	NMOD
14	required	require	B-VP	VBD	O	13	SBAR
15	admission	admission	B-NP	NN	O	14	OBJ
16	to	to	B-PP	TO	O	14	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	intensive	intensive	I-NP	JJ	O	20	NMOD
19	care	care	I-NP	NN	O	20	NMOD
20	unit	unit	I-NP	NN	O	22	NMOD
21	or	or	O	CC	O	22	NMOD
22	colectomy	colectomy	B-NP	NN	O	16	PMOD
23	,	,	O	,	O	9	P
24	or	or	O	CC	O	9	VMOD
25	died	die	B-VP	VBD	O	9	VMOD
26	,	,	O	,	O	25	P
27	within	within	B-PP	IN	O	25	VMOD
28	30	30	B-NP	CD	O	29	NMOD
29	days	day	I-NP	NNS	O	27	PMOD
30	of	of	B-PP	IN	O	29	NMOD
31	CDI	CDI	B-NP	NN	O	32	NMOD
32	diagnosis	diagnosis	I-NP	NN	O	30	PMOD
33	.	.	O	.	O	9	P

1	Logistic	Logistic	B-NP	JJ	O	3	NMOD
2	regression	regression	I-NP	NN	O	3	NMOD
3	models	model	I-NP	NNS	O	4	SUB
4	were	be	B-VP	VBD	O	0	ROOT
5	used	use	I-VP	VBN	O	4	VC
6	to	to	B-VP	TO	O	7	VMOD
7	identify	identify	I-VP	VB	O	5	VMOD
8	variables	variable	B-NP	NNS	O	7	OBJ
9	that	that	B-NP	WDT	O	8	NMOD
10	were	be	B-VP	VBD	O	9	SBAR
11	independently	independently	I-VP	RB	O	10	VMOD
12	associated	associate	I-VP	VBN	O	10	VC
13	with	with	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	occurrence	occurrence	I-NP	NN	O	13	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	severe-complicated	severe-complicated	B-NP	JJ	O	18	NMOD
18	CDI	CDI	I-NP	NNP	O	16	PMOD
19	in	in	B-PP	IN	O	15	NMOD
20	2	2	B-NP	CD	O	21	NMOD
21	cohorts	cohort	I-NP	NNS	O	19	PMOD
22	.	.	O	.	O	4	P

1	One	One	B-NP	CD	O	2	NMOD
2	cohort	cohort	I-NP	NN	O	3	SUB
3	comprised	comprise	B-VP	VBD	O	10	VMOD
4	all	all	B-NP	DT	O	6	NMOD
5	hospitalized	hospitalize	I-NP	VBN	O	6	NMOD
6	patients	patient	I-NP	NNS	O	3	OBJ
7	;	;	O	:	O	10	P
8	the	the	B-NP	DT	O	9	NMOD
9	other	other	I-NP	JJ	O	10	SUB
10	comprised	comprise	B-VP	VBD	O	0	ROOT
11	a	a	B-NP	DT	O	12	NMOD
12	subset	subset	I-NP	NN	O	10	OBJ
13	of	of	B-PP	IN	O	12	NMOD
14	these	these	B-NP	DT	O	15	NMOD
15	inpatients	inpatient	I-NP	NNS	O	13	PMOD
16	who	who	B-NP	WP	O	12	NMOD
17	were	be	B-VP	VBD	O	16	SBAR
18	residents	resident	B-NP	NNS	O	17	PRD
19	of	of	B-PP	IN	O	18	NMOD
20	Olmsted	Olmsted	B-NP	NNP	O	21	NMOD
21	County	County	I-NP	NNP	O	19	PMOD
22	,	,	O	,	O	10	P
23	Minnesota	Minnesota	B-NP	NNP	O	10	VMOD
24	to	to	B-VP	TO	O	25	VMOD
25	assess	assess	I-VP	VB	O	23	NMOD
26	the	the	B-NP	DT	O	27	NMOD
27	association	association	I-NP	NN	O	25	OBJ
28	of	of	B-PP	IN	O	27	NMOD
29	comorbid	comorbid	B-NP	JJ	O	30	NMOD
30	conditions	condition	I-NP	NNS	O	28	PMOD
31	with	with	B-PP	IN	O	27	NMOD
32	the	the	B-NP	DT	O	33	NMOD
33	development	development	I-NP	NN	O	31	PMOD
34	of	of	B-PP	IN	O	33	NMOD
35	severe-complicated	severe-complicated	B-NP	JJ	O	36	NMOD
36	infection	infection	I-NP	NN	O	34	PMOD
37	in	in	B-PP	IN	O	27	NMOD
38	a	a	B-NP	DT	O	40	NMOD
39	population-based	population-based	I-NP	JJ	O	40	NMOD
40	cohort	cohort	I-NP	NN	O	37	PMOD
41	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	3	NMOD
2	linear	linear	I-NP	JJ	O	3	NMOD
3	combinations	combination	I-NP	NNS	O	12	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	variables	variable	B-NP	NNS	O	4	PMOD
6	identified	identify	B-VP	VBN	O	5	NMOD
7	by	by	B-PP	IN	O	6	VMOD
8	using	use	B-VP	VBG	O	7	PMOD
9	logistic	logistic	B-NP	JJ	O	11	NMOD
10	regression	regression	I-NP	NN	O	11	NMOD
11	models	model	I-NP	NNS	O	8	OBJ
12	provided	provide	B-VP	VBD	O	0	ROOT
13	scores	score	B-NP	NNS	O	15	SUB
14	to	to	B-VP	TO	O	15	VMOD
15	predict	predict	I-VP	VB	O	12	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	risk	risk	I-NP	NN	O	15	OBJ
18	of	of	B-PP	IN	O	17	NMOD
19	developing	develop	B-VP	VBG	O	18	PMOD
20	severe-complicated	severe-complicated	B-NP	JJ	O	21	NMOD
21	CDI	CDI	I-NP	NNP	O	19	OBJ
22	.	.	O	.	O	12	P

1	In	In	B-PP	IN	O	42	VMOD
2	a	a	B-NP	DT	O	4	NMOD
3	multivariable	multivariable	I-NP	JJ	O	4	NMOD
4	model	model	I-NP	NN	O	1	PMOD
5	that	that	B-NP	WDT	O	4	NMOD
6	included	include	B-VP	VBD	O	5	SBAR
7	all	all	B-NP	DT	O	8	NMOD
8	inpatients	inpatient	I-NP	NNS	O	6	OBJ
9	,	,	O	,	O	42	P
10	increasing	increase	B-VP	VBG	O	11	NMOD
11	age	age	B-NP	NN	O	20	NMOD
12	,	,	O	,	O	20	P
13	leukocyte	leukocyte	B-NP	NN	O	20	NMOD
14	count	count	I-NP	NN	O	20	NMOD
15	>	>	O	SYM	O	20	NMOD
16	15 × 10	15 × 10	B-NP	CD	O	20	NMOD
17	(	(	O	(	O	19	DEP
18	9	9	B-NP	CD	O	19	DEP
19	)	)	O	)	O	16	NMOD
20	/L	/L	B-NP	NN	O	34	NMOD
21	,	,	O	,	O	34	P
22	increase	increase	B-NP	NN	O	34	NMOD
23	in	in	B-PP	IN	O	22	NMOD
24	serum	serum	B-NP	NN	O	25	NMOD
25	level	level	I-NP	NN	O	23	PMOD
26	of	of	B-PP	IN	O	25	NMOD
27	creatinine	creatinine	B-NP	NN	O	26	PMOD
28	>	>	B-NP	SYM	O	27	NMOD
29	1.5-fold	1.5-fold	B-ADVP	RB	O	30	PMOD
30	from	from	B-PP	IN	O	28	AMOD
31	baseline	baseline	B-NP	NN	O	30	PMOD
32	,	,	O	,	O	34	P
33	and	and	O	CC	O	34	NMOD
34	use	use	B-NP	NN	O	42	SUB
35	of	of	B-PP	IN	O	34	NMOD
36	proton	proton	B-NP	NN	O	38	NMOD
37	pump	pump	I-NP	NN	O	38	NMOD
38	inhibitors	inhibitor	I-NP	NNS	O	41	NMOD
39	or	or	O	CC	O	41	NMOD
40	narcotic	narcotic	B-NP	JJ	O	41	NMOD
41	medications	medication	I-NP	NNS	O	35	PMOD
42	were	be	B-VP	VBD	O	0	ROOT
43	independently	independently	I-VP	RB	O	42	VMOD
44	associated	associate	I-VP	VBN	O	42	VC
45	with	with	B-PP	IN	O	44	VMOD
46	severe-complicated	severe-complicated	B-NP	JJ	O	47	NMOD
47	CDI	CDI	I-NP	NNP	O	45	PMOD
48	.	.	O	.	O	42	P

1	In	In	B-PP	IN	O	16	VMOD
2	the	the	B-NP	DT	O	4	NMOD
3	secondary	secondary	I-NP	JJ	O	4	NMOD
4	analysis	analysis	I-NP	NN	O	1	PMOD
5	,	,	O	,	O	16	P
6	which	which	B-NP	WDT	O	16	SUB
7	included	include	B-VP	VBD	O	6	SBAR
8	only	only	B-NP	RB	O	9	NMOD
9	patients	patient	I-NP	NNS	O	7	OBJ
10	from	from	B-PP	IN	O	9	NMOD
11	Olmsted	Olmsted	B-NP	NNP	O	12	NMOD
12	County	County	I-NP	NNP	O	10	PMOD
13	,	,	O	,	O	15	P
14	comorbid	comorbid	B-NP	JJ	O	15	NMOD
15	conditions	condition	I-NP	NNS	O	6	NMOD
16	were	be	B-VP	VBD	O	0	ROOT
17	not	not	I-VP	RB	O	16	VMOD
18	significantly	significantly	I-VP	RB	O	16	VMOD
19	associated	associate	I-VP	VBN	O	16	VC
20	with	with	B-PP	IN	O	19	VMOD
21	severe-complicated	severe-complicated	B-NP	JJ	O	22	NMOD
22	CDI	CDI	I-NP	NNP	O	20	PMOD
23	.	.	O	.	O	16	P

1	Older	Old	B-NP	JJR	O	2	NMOD
2	age	age	I-NP	NN	O	5	NMOD
3	,	,	O	,	O	5	P
4	high	high	B-NP	JJ	O	5	NMOD
5	numbers	number	I-NP	NNS	O	24	NMOD
6	of	of	B-PP	IN	O	5	NMOD
7	leukocytes	leukocyte	B-NP	NNS	B-cell_type	6	PMOD
8	in	in	B-PP	IN	O	7	NMOD
9	blood	blood	B-NP	NN	B-cell_type	10	NMOD
10	samples	sample	I-NP	NNS	I-cell_type	15	NMOD
11	,	,	O	,	O	15	P
12	an	an	B-NP	DT	O	15	NMOD
13	increased	increase	I-NP	VBN	O	15	NMOD
14	serum	serum	I-NP	NN	O	15	NMOD
15	level	level	I-NP	NN	O	8	PMOD
16	of	of	B-PP	IN	O	15	NMOD
17	creatinine	creatinine	B-NP	NN	O	16	PMOD
18	,	,	O	,	O	24	P
19	gastric	gastric	B-NP	JJ	O	21	NMOD
20	acid	acid	I-NP	NN	O	21	NMOD
21	suppression	suppression	I-NP	NN	O	24	NMOD
22	,	,	O	,	O	24	P
23	and	and	O	CC	O	24	NMOD
24	use	use	B-NP	NN	O	28	SUB
25	of	of	B-PP	IN	O	24	NMOD
26	narcotic	narcotic	B-NP	JJ	O	27	NMOD
27	medications	medication	I-NP	NNS	O	25	PMOD
28	were	be	B-VP	VBD	O	0	ROOT
29	independently	independently	I-VP	RB	O	28	VMOD
30	associated	associate	I-VP	VBN	O	28	VC
31	with	with	B-PP	IN	O	30	VMOD
32	development	development	B-NP	NN	O	31	PMOD
33	of	of	B-PP	IN	O	32	NMOD
34	severe-complicated	severe-complicated	B-NP	JJ	O	35	NMOD
35	CDI	CDI	I-NP	NNP	O	33	PMOD
36	in	in	B-PP	IN	O	32	NMOD
37	hospitalized	hospitalize	B-NP	VBN	O	38	NMOD
38	patients	patient	I-NP	NNS	O	36	PMOD
39	.	.	O	.	O	28	P

1	Early	Early	B-NP	RB	O	2	AMOD
2	aggressive	aggressive	I-NP	JJ	O	6	SUB
3	monitoring	monitoring	I-NP	NN	O	2	NMOD
4	and	and	I-NP	CC	O	2	NMOD
5	intervention	intervention	I-NP	NN	O	2	NMOD
6	could	could	B-VP	MD	O	0	ROOT
7	improve	improve	I-VP	VB	O	6	VC
8	outcomes	outcome	B-NP	NNS	O	7	OBJ
9	.	.	O	.	O	6	P

